NDRG2 antagonizes transforming growth factor-β1 (TGF-β1)-mediated tumor cell invasion by down-regulating the expression of matrix metalloproteinase 2 (MMP2), plasminogen activator inhibitor type 1 (PAI-1) and Rho GTPase activity [7]. This evidence concerns the gene MMP2 and neoplasm.